Demographics and distribution of intravitreal injections in the pediatric age group between 2008 and 2025
Authors:
- Ozlem Ural FatihogluOzlem Ural Fatihoglu
- Kagan KaracabagKKKagan Karacabag
- Hamit AliHAHamit Ali
- Omer KartiOKOmer Karti
- Ziya AyhanZAZiya Ayhan
- Taylan OzturkTOTaylan Ozturk
- Ali Osman SaatciASAli Osman Saatci
Open Access
- 17 June 2026
- journal article
- Published by Elsevier in AJO International
- Vol. 3 (3)
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ SystemsOphthalmology and Therapy, 2025
- Clinical Characteristics and Treatment Outcomes in Unilateral Coats DiseaseOphthalmology Retina, 2024
- Sustained remission of pediatric choroidal neovascular membrane secondary to choroidal rupture with intravitreal afliberceptCanadian Journal of Ophthalmology, 2024
- Sex differences in the risk of retinopathy of prematurity: a systematic review, frequentist and Bayesian meta-analysis, and meta-regressionWorld Journal of Pediatrics, 2023
- Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of PrematurityJAMA, 2022
- Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trialThe Lancet, 2019
- Recurrence of SRF Post Intravitreal Ranibizumab for Pediatric Choroidal Neovascularisation Secondary to Best DiseaseOcular Immunology and Inflammation, 2019
- Steroid-induced glaucoma in the pediatric populationJournal of American Association for Pediatric Ophthalmology and Strabismus, 2017
- Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseasesJournal of American Association for Pediatric Ophthalmology and Strabismus, 2015
- Intravitreal bevacizumab for pediatric exudative retinal diseasesSaudi Journal of Ophthalmology, 2011